Zelboraf, Cotellic, Similar Melanoma Drugs May Cause Heart Problems: Study
A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.
A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.
Roche has temporarily halted a clinical trial of a combination of the cancer drugs Tecentriq and Cotellic following the deaths of several patients involved in the study.